In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Illumina acquires Verinata for $350mm

Executive Summary

Illumina Inc. (diagnostics) has agreed to acquire closely held prenatal testing firm Verinata Health Inc. for $350mm up front, plus up to $100mm in earn-outs through 2015.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Full Acquisition
    • Acquisition of Private Biotech
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register